Use of a physiotherapeutic device for complex treatment of inflammatory diseases of prostate

Cover Page


Cite item

Full Text

Abstract

Aim. Evaluation of efficacy of complex treatment of patients with the diagnosis of chronic prostatitis and patients with the main diagnosis of benign prostatic hyperplasia and concomitant chronic prostatitis with the use of physiotherapeutic device for the treatment of inflammatory prostatic diseases «MAVIT».

Methods. Clinical efficacy of the treatment with the use of the «MAVIT» device was studied in complex treatment of 45 patients with chronic prostatitis. Group 1 consisted of 25 patients diagnosed with stage I-II benign prostatic hyperplasia complicated with chronic prostatitis. Group 2 included 20 patients with proven diagnosis of chronic prostatitis. Efficacy was evaluated immediately after the course of treatment and during the following 12 months. For evaluation of biotissue influence of the «MAVIT» device on blood flow in prostate, transrectal color Doppler ultrasound was performed in 10 patients from group 2 before and after physiotherapeutic session. Peak flow rate, index of peripheral vascular resistance as well as organ vascular density were studied.

Results. The treatment results were evaluated in both groups at months 3 to 12. All patients reported reduction or disappearance of dysuria, subjective improvement of urination, reduction of pain in genitals. Improvement of urination was registered based on the results of examination (IPSS scale, uroflowmetry, ultrasound of prostate, residual urine, transrectal color Doppler ultrasound).

Conclusion. In patients with symptomatic benign prostatic hyperplasia at conservative stage of the disease complex treatment of chronic prostatitis with the use of physiotherapeutic factors has pathogenetic value and, if necessary, allows preparing a patient for the surgery; the received results allow recommending the «MAVIT» device for the treatment of chronic prostatitis including patients with stage I-II benign prostatic hyperplasia.

About the authors

B N Zhiborev

Ryazan State Medical University named after Academician I.P. Pavlov; City Clinical Hospital №11

Author for correspondence.
Email: zhiborev@yandex.ru
Ryazan, Russia; Ryazan, Russia

A B Zhiborev

City Clinical Hospital №11

Email: zhiborev@yandex.ru
Ryazan, Russia

B Yu Rakcheev

City Clinical Hospital №11

Email: zhiborev@yandex.ru
Ryazan, Russia

References

  1. Verhamme K.M.C., Dieleman J.P., Bleumink G.S. et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - The Triumph Project. Eur. Urol. 2002; 42: 323-328. doi: 10.1016/S0302-2838(02)00354-8.
  2. Ficarra V., Rossanese M., Zazzara M. et al. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy. Curr. Urol. Rep. 2014; 15 (12): 463. doi: 10.1007/s11934-014-0463-9.
  3. Huang X.H., Qin B., Liang Y.W. et al. LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate. Zhonghua Nan Ke Xue. 2013; 19 (1): 35-39.
  4. Urkmez A., Yuksel O.H., Uruc F. et al. The effect of asymptomatic histological prostatitis on sexual function and lower urinary tract symptoms. Arch. Esp. Urol. 2016; 69 (4): 185-191.
  5. Кудрявцев Ю.В., Романова Л.М. Морфологические изменения в ткани предстательной железы при доброкачественной гиперплазии. В кн.: Доброкачественная гиперплазия предстательной железы. Под ред. Н.А. Лопаткина. М.: Наука. 1999; 44.
  6. Кирпатовский В.И., Сивков А.В., Федяков Р.П. и др. Роль нарушения кровоснабжения и тканевой гипоксии в развитии дисфункции мочевого пузыря при инфравезикальной обструкции, вызванной аденомой предстательной железы. Урология. 2013; (2): 123-128.
  7. Kogan M.I., Belousov I.I., Shangichev A.V. Whether dyslipidemia plays the pathogenetic role in the development of noninflammatory chronic prostatitis/chronic pelvic pain syndrome? Urologiia. 2012; (5): 46-52.
  8. Kozlowski R., Kershen R.T., Siroky M.B. et al. Chronic ischemia alters prostate structure and reactivity in rabbits. J. Urol. 2001; 165 (3): 1019-1026. doi: 10.1016/S0022-5347(05)66595-0.
  9. Allen S., Aghajanyan I.G. Benign prostatic hyperplasia treatment with new physiotherapeutic device. Urol. J. 2015; 12 (5): 2371-2376.
  10. Kessler T.M., Mordasini L., Weisstanner C. et al. Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo-controlled, double-blind trial. PLoS One. 2014; 9 (12): e113368. doi: 10.1371/journal.pone.0113368.
  11. Лоран О.Б. Диагностика и дифференциальная диагностика доброкачественной гиперплазии предстательной железы. В кн.: Доброкачественная гиперплазия предстательной железы. Под ред. Н.А. Лопаткина. М.: Наука. 1999; 56-70.
  12. Kiyatkin V.A., Konchugova T.V., Yakovlev M.Y., Bobkov A.D. The application of the combined resonance-wave therapy for the treatment of the patients presenting with chronic bacterial prostatitis. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. 2015; 92 (5): 40-44. doi: 10.17116/kurort2015540-44.
  13. Аполихин О.И., Сивков А.В., Ощепков В.Н. Термальные неэндоскопические методы лечения ДГПЖ. В кн.: Доброкачественная гиперплазия предстательной железы. Под ред. Н.А. Лопаткина. М.: Наука. 1999; 134-149.
  14. Сучкова Ж.Н. Локальная магнитотерапия. Медицинская газета. 2001; (62): 9-13.
  15. Улащик В.С. Новые методы и методики физической теории. Минск: Беларусь. 1986; 176 с.
  16. Гайдуков В.П., Жиборев Б.Н., Жиборев А.Б. и др. Устройство для физиотерапевтического воздействия на ткани полостей организма. Патент №2291678. Бюлл. №2 от 20.01.2007. http://www.freepatent.ru/patents/2291678.
  17. Системы комплексной электромагнитотерапии. Учебное пособие для вузов. Под ред. А.М. Беркутова, В.И. Жулёва, Г.А. Кураева, Е.М. Прошина. М.: Бином. 2000; 376 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2017 Zhiborev B.N., Zhiborev A.B., Rakcheev B.Y.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies